The terms interactive and dynamic would never have been associated with psychological and psychoeducational assessment a generation ago. They have currency now because of widespread dissatisfaction with the normative, standardized testing model, criticism of theoretical concepts of intelligence, recognition of abuses of standardized intelligence testing, and frustration with prediction and classification as primary goals of assessment. It is almost certainly true that public policy concerns propel scientific activity far more often than science propels public policy In the case of psychological assessment, public policy concerns have arisen in the last 20 years primarily around issues of possible "discrimination" against members of ethnic minorities. At the same time, there has been a re surgence of dedication to "excellence in education" goals. These concerns have led to such extreme measures as prohibition of the use of standard ized intelligence tests to determine school placement decisions, especially for minority children. They have led also to a search for alternatives to standardized, normative testing. The chapters in this volume represent a variety of answers to this need."

This book could not have been conceptualized or published 20 years ago. Indeed, it is doubtful that we could have organized the material for this handbook 10 years ago. Over the last 20 years, however, the painstaking efforts of many clinical researchers working with a variety of resistive psychopathologies have resulted in specific psychotherapies and pharmacotherapies that are effective with a significant propor tion of patients, at least for some of the disorders. Much clinical research remains to be carried out in the forthcoming decades. But now that we are nearing the 21st century, at least some statement about efficacy can be made. In 1967, Gordon Paul succinctly stated that the ultimate goal of treatment outcome research is to determine "What treatment, by whom, is most effective for this individual with that specific problem, and under which set of circumstances" (p. 111). At that time, empirical evaluations of psychosocial and pharmacologic treatments were few and far between. Methodological strategies for determining treatment effectiveness were also in the formative stage, as exemplified by introduc tion of control groups that received inactive interventions (i. e., placebo) and the relatively recent practice of comparing two or more treatments in addition to placebo. In the almost three decades since Paul's oft-quoted dictum, both the quantity and the quality of treatment outcome research with adults have increased dramati cally."

The Future of Mental Health drills to the heart of the current mental health crisis, where hundreds of millions of individuals worldwide receive unwarranted "mental disorder diagnoses." It paints a picture of how mental health providers can improve their practices to better serve individuals in distress and outlines necessary steps for a mental health revolution. Eric Maisel's goal is to inject more human interaction into the therapeutic process. Maisel powerfully deconstructs the "mental disorder" paradigm that is the foundation of current mental health practices. The author presents a revolutionary alternative, a "human experience" paradigm. He sheds a bright light on the differences between so-called "psychiatric medication" and mere chemicals with powerful effects, explains why the DSM-5 is silent on causes, silent on treatment, and wedded to illegitimate "symptom pictures." Maisel describes powerful helping alternatives like communities of care, and explains why one day "human experience specialists" may replace current mental health professionals. An important book for both service providers and service users, The Future of Mental Health brilliantly unmasks current mental health practices and goes an important step further: it describes what we are obliged to do in order to secure better mental health services-and better mental health-for everyone.

Chronic and excessive alcohol consumption disrupts a number of biologic sys tems. Central nervous system pathology, associated with long-standing alcohol ingestion, has particularly deleterious consequences to the individual. Compro mising brain functional integrity ultimately militates against psychosocial ad justment, and this process is inevitably reflected as a substantial economic loss to society in the form of costs for providing medical and social services, as well as disability and absenteeism from work. This book marshals the literature pertinent to the effects of chronic alcohol abuse on brain structure and functioning. The material is divided into two parts: basic research and clinical issues. In the first section, the manifest neurologic consequences are described across the different levels of biologic organization, these being brain morphology, neurochemistry, neurophysiology, and neuro psychology. In recognition of the multifactorial etiology of alcohol-related brain pathology, the influence and role of hepatic, endocrine, and nutritional factors are also examined. The second section addresses clinical syndromes and dis orders. It will be noted that evidence accrued from recent research suggests that neurologic disturbances may actually antedate the onset of drinking in some alcoholics. Other clinically important issues discussed are the effects of alcohol on neurologic development, aging, and dementia. The book concludes with a discussion of the alcohol withdrawal syndrome, its mechanisms and manifes tations. A fundamental objective of the editors was to illustrate that the consequences of chronic alcohol excess can be comprehensively understood within the per spective of interrelated hierarchical systems of brain organization."

Comprehensive Pharmacology, Seven Volume Set is organized into twelve sections that explore therapeutic areas, with a total of 320 comprehensive articles and 6,800 pages of important findings. Sections contain highly detailed coverage of information that has been overseen by an editorial board made up of well-respected, field leading experts. The content in this book offers readers an in-depth and easily accessible reference work on every aspect of pharmacological research surrounding the pharmacology of all therapeutic applications of drugs, their mechanism of action and their therapeutic values. These elements are essential as drugs are almost never tested and developed in the actual therapeutic system, but rather in test systems from which parameters must be determined to predict activity in systems of varying ambient physiology. As different technologies rapidly evolve, there is an ever-increasing level of knowledge about the pharmacology of known drugs, along with increasing capability to utilize pharmacological systems to predict new drug activity, all of which must be communicated to professionals in varying fields.

A landmark publication in the field, this state of the art reference work includes contributions from leading thinkers across a range of disciplines on topics including ADHD, autism, depression, eating disorders and trauma. It is an essential resource for all those involved or interested in child mental health.

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), is the most comprehensive, current, and critical resource for clinical practice available to today's mental health clinicians and researchers. DSM-5-TR includes the fully revised text and references, updated diagnostic criteria and ICD-10-CM codes since DSM-5 was published in 2013. It features a new disorder, Prolonged Grief Disorder, as well as codes for suicidal behavior available to all clinicians of any discipline without the requirement of any other diagnosis. With contributions from over 200 subject matter experts, this updated volume boasts the most current text updates based on the scientific literature. Now in four-color and with the ability to authenticate each printed copy, DSM-5-TR provides a cohesive, updated presentation of criteria, diagnostic codes, and text. This latest volume offers a common language for clinicians involved in the diagnosis and study of mental disorders and facilitates an objective assessment of symptom presentations across a variety of clinical settings-inpatient, outpatient, partial hospital, consultation-liaison, clinical, private practice, and primary care. Stay current with these important updates in DSM-5-TR: * Fully revised text for each disorder with updated sections on associated features, prevalence, development and course, risk and prognostic factors, culture, diagnostic markers, suicide, differential diagnosis, and more.* Addition of Prolonged Grief Disorder (PGD) to Section II-a new disorder for diagnosis* Over 70 modified criteria sets with helpful clarifications since publication of DSM-5* Fully updated Introduction and Use of the Manual to guide usage and provide context for important terminology* Considerations of the impact of racism and discrimination on mental disorders integrated into the text* New codes to flag and monitor suicidal behavior, available to all clinicians of any discipline and without the requirement of any other diagnosis* Fully updated ICD-10-CM codes implemented since 2013, including over 50 coding updates new to DSM-5-TR for substance intoxication and withdrawal and other disorders* Updated and redesigned Diagnostic Classification This manual is a valuable resource for other physicians and health professionals, including psychologists, counselors, nurses, and occupational and rehabilitation therapists, as well as social workers and forensic and legal specialists. The new DSM-5-TR is the most definitive resource for the diagnosis and classification of mental disorders.

This book focuses on the priority that psychoanalysis places on the individual, how the treatment is conceived theoretically and the ways it can be incorporated in the overall organisation of an institution. It brings together the histories of a number of psychoanalytically informed hospitals.

This book offers a collection of original contributions to current research available on Circles of Support and Accountability (CoSA) by engaging with current literature and unpublished research in the field. The book explores the role of narrative identity in desistance from sexual crime and how CoSA maps onto this, as well as a history of CoSA across the world. The text then moves into an empirical section, reporting on some unpublished findings, including an evaluation of a new prison-based CoSA in the UK. Lastly, the experiences of service users and the influence of media perceptions are explored, offering a space for the 'unheard voices' as well as consideration of future directions for practitioners. The book is relevant not just to psychologists, criminologists, social workers and students, but to practitioners and the general public with an interest in learning about CoSA. The editors of this volume have all been involved in the setting up of the Safer Living Foundation, a charity formed in 2014 to reduce and prevent sexual offending.

This book puts the critical into dementia studies. It makes a timely and novel contribution to the field, offering a provocative and thought-provoking critique of current thinking and debate on dementia. Collectively the contributions gathered together in this text make a powerful case for a more politically engaged, deconstructive and critical treatment of dementia and the systems and structures that currently govern and frame it. The book is interdisciplinary and draws together leading dementia scholars alongside dementia activists from around the world. It frames dementia as first and foremost a political category. The book advances both theoretical and methodological thinking in the field as well as sharing learning from empirical research. Outlining the limits to existing efforts to frame and theorise the condition it proposes a new critical movement for the field of dementia studies and practice. The book will be of direct interest to researchers and scholars in the field of dementia studies and wider fields of health, disability and care. It will provide a novel resource for students and practitioners in the fields of dementia, health care and social care. The book also has implications for dementia policymaking, commissioning and community development.

Bringing together contributions by leaders in the field of clinical psychology, this highly readable textbook provides a current perspective on theory, training, assessment, consultation, research, and outpatient and inpatient practice. Bridging the gap between theory and practice, contributors offer a professional perspective on the various specialized activities and settings of a clinical psychologist. With this unique insight, advanced undergraduate and beginning graduate students gain a realistic understanding of the life of a clinical psychologist as well as the diverse professional opportunities in the field.

Time pervades every aspect of people's lives. We are all affected by remnants of our pasts, assessments of our presents, and forecasts of our futures. Our thoughts, feelings, and behaviors over time inexorably intertwine and intermingle, determining varied reactions such as affect and emotions, as well as future behaviors. The purpose of this volume is to bring together the diverse theory and research of an outstanding group of scholars whose work relates to peoples judgements over time. To date, much theory and research on temporal variables within psychology has remained somewhat fragmented, isolated, and even provincial--researchers in particular domains are either unaware of or are paying little attention to each other's work. Integrating the theory and research into a single volume will bring about a greater awareness and appreciation of conceptual relations between seemingly disparate topics, define and promote the state of scientific knowledge in these areas, and set the agenda for future work. The volume presents the two main ways of looking at judgments over time: looking at how people's thoughts about the future and the past affect their present states, and looking at the interplay over time among people's thoughts, feelings, and behaviors.

The purpose of this book is to be the premier resource for behavioural health clinicians who are considering adopting technology into their practice. Written by experts and policy makers in the field this book will be recognized as the gold standard. Other books currently in this field are extremely technical and are geared primarily to policy makers, researchers and informaticians. While this book will be a useful adjunct to that audience, it is primarily designed for the over .5 million behavioural health clinicians in the U.S. and the millions others around the world. Adoption of technology is slow in behavioural healthcare, and this book will enhance the adoption and utilization of various technologies in practice. I.T. vendors may also purchase this book for their customers.

"Resilience in Children, Adolescents, and Adults: Translating Research into Practice "recognizes the growing need to strengthen the links between theory, assessment, interventions, and outcomes to give resilience a stronger empirical base, resulting in more effective interventions and strength-enhancing practice. This comprehensive volume clarifies core constructs of resilience and links these definitions to effective assessment. Leading researchers and clinicians examine effective scales, questionnaires, and other evaluative tools as well as instructive studies on cultural considerations in resilience, resilience in the context of disaster, and age-appropriate interventions.

Key coverage addresses diverse approaches and applications in multiple areas across the lifespan. Among the subject areas covered are:

- Perceived self-efficacy and its relationship to resilience.
- Resilience and mental health promotion in the schools.
- Resilience in childhood disorders.
- Critical resources for recovering from stress.
- Diversity, ecological, and lifespan issues in resilience.
- Exploring resilience through the lens of core self-evaluation.

"Resilience in Children, Adolescents, and Adults" is an important resource for researchers, clinicians and allied professionals, and graduate students in such fields as clinical child, school, and developmental psychology, child and adolescent psychiatry, education, counseling psychology, social work, and pediatrics.

Sleep-wake disorders frequently give rise to severe ailments and varied distresses in a great number of people in the world, disturbing their physical and mental activities and their social function. Sleep-wake disorders are now classified into a great number of cate gories according to their clinical features and etiological factors. Patients with sleep-wake disorders are taken care of not only by specialists for such disorders but also by general physicians and specialists of different physical and mental disorders. In the recent years, the nature of sleep and sleep-wake disorders have been intensively studied by investiga tors belonging to different fields of science including medicine, biology, and psychology in many countries. It is very important for the progress of research that investigators work ing in the related fields in different countries meet together and exchange their findings and ideas. The Japanese-German International Symposium on Sleep-Wake Disorders was held on October 9-10th, 1996 in the old, beautiful city of Erfurt (Germany). This symposium was organized by Professor Karlheinz Meier-Ewert (Schwalmstadt, Germany) and Dr. Masako Okawa (Ichikawa, Japan), with support of the German Society of Sleep Research (President at that time, Professor J. H. Peter) and of the Japanese Society of Sleep Research (President at that time, Professor Y. Hishikawa)."

Valproic acid was first synthesized in 1882 by Burton, but there was no known clinical use until its anticonvulsant activity was fortuitously discovered by H. Meunier in 1963 in the laboratory of G. Carraz. The first clinical trials of the sodium salt of valproate were reported in 1964 by Carraz. It was marketed in France in 1967 and was released in the United States in 1978 for the treatment of epilepsy. Since then, valproate has established itself worldwide as a major antiepileptic drug against several types of seizures. Clinical experience with valproate has continued to grow in recent years, including use of valproate for diseases other than epilepsy, for example in bipolar disorders and migraine. In this book, emphasis is placed on the scientific background leading to the discovery of valproate and its clinical development into one of the most widely and successfully used antiepileptic drugs, a real milestone in drug therapy. The current state of knowledge of valproate is reviewed by experts in the field, including new hypotheses on its mechanisms of action, its metabolism into pharmacologically active metabolites, its unique distribution characteristics, its undesirable hepatotoxic and teratogenic adverse effects, and its various clinical uses. The monograph is aimed at a broad readership, particularly neurologists, psychiatrists and basic scientists working in the field of epilepsy research. Furthermore, the book also deals with structure-activity relationships of valproate as well as of its metabolites and analogs and should therefore attract researchers working in medicinal chemistry.

This unique handbook covers the consensuses and controversies surrounding traditional and nontraditional psychotherapeutic methodologies as related to individuals and specific subpopulations. It is the most comprehensive, integrative resource available to the graduate level student and to the practicing clinician.

This book examines the current research in gene-environment transactions (GEX) and its potential use in developing interventions and applications tailored to individual genetic makeups. Key concepts underlying GEX studies in this area are defined, identifying fundamental challenges in devising informed research questions and conducting valid and useful experiments. Chapters analyze GEX models inspired by the present day genome-based frameworks, particularly in terms of advances in identifying and understanding complex environmental factors, using examples from common psychological conditions, such as antisocial behavior, chronic physical aggression, and chronic internalizing disorder. In addition, the book presents new and potential applications of the framework in the contexts of prevention science and intervention research. Topics featured in this book include: Epigenetics and the biology of gene x environment interactions. Gene by environment interactions and its potential use for intervention strategies in anxiety disorders. The challenges and potential for research on gene-environment interactions within autism spectrum disorder. Using genetically informed prevention trials to test gene x environment hypothese. Challenges for intervention research within the GEX framework. Gene-Environment Transactions in Developmental Psychopathology is a must-have resource for researchers/professors, clinicians, and related professionals as well as graduate students in developmental psychology, psychiatry, human genetics, and related disciplines.

Interest in techniques to control the brain and thereby improve its function has surged, yet how realistic are these expectations and what are the ethical implications? This book reviews the main techniques of controlling brain processes for medical purposes, situating them within ethical and legal debates on autonomy and fairness.

Product information not available.

The cat lady. The couple who won't let anyone in their apartment. The old man with all that junk in his yard. Their severe hoarding puts them, and often others, at risk for injury, disease, and even death. Most deny needing help, and for this reason, professionals are desperate to find more effective ways to offer and provide assistance to them. In response to this growing public health problem, Clinician's Guide to Severe Hoarding refines our understanding and presents in depth and innovative alternative to traditional interventions. Arguing that although treatment for hoarding can be effective for those who are open to help, people with severe hoarding are not. The Clinician's Guide to Severe Hoarding describes an alternative strategy to help those who adamantly refuse help and yet face significant health and safety risks due to the hoarding problem - harm reduction. This client-centered approach takes readers through harm reduction plan development, team building, goal setting, client collaboration, and progress assessment. The Clinician's Guide also explains that a successful harm reduction plan may encourage clients to seek further help, and offers insights into working with special populations such as people who hoard animals and children who exhibit hoarding behavior. The Clinician's Guide describes in detail a range of strategies for assisting people with severe hoarding: Strategies for engaging with clients who hoard. Guidelines for assessing harm potential. Guidelines for creating a harm reduction plan, building a harm reduction team, and conducting and evaluating home visits. Skills for client self-help: decision making, time management, and more. Guidelines for navigating the ethical and legal issues that arise in assisting people who hoard. Readings, links, and other resources. With its practical common-sense approach to a complex problem, Clinician's Guide to Severe Hoarding is a unique volume not only for mental health practitioners, but also other professionals who assist people who hoard, such as home health aides, social workers, and professional organizers.

The fact that tobacco ingestion can affect how people feel and think has been known for millennia, placing the plant among those used spiritually, honori?cally, and habitually (Corti 1931; Wilbert 1987). However, the conclusion that nicotine - counted for many of these psychopharmacological effects did not emerge until the nineteenth century (Langley 1905). This was elegantly described by Lewin in 1931 as follows: "The decisive factor in the effects of tobacco, desired or undesired, is nicotine. . . "(Lewin 1998). The use of nicotine as a pharmacological probe to und- stand physiological functioning at the dawn of the twentieth century was a landmark in the birth of modern neuropharmacology (Limbird 2004; Halliwell 2007), and led the pioneering researcher John Langley to conclude that there must exist some "- ceptive substance" to explain the diverse actions of various substances, including nicotine, when applied to muscle tissue (Langley 1905). Research on tobacco and nicotine progressed throughout the twentieth century, but much of this was from a general pharmacological and toxicological rather than a psychopharmacological perspective (Larson et al. 1961). There was some attention to the effects related to addiction, such as euphoria (Johnston 1941), tolerance (Lewin 1931), and withdrawal (Finnegan et al. 1945), but outside of research supported by the tobacco industry, addiction and psychopharmacology were not major foci for research (Slade et al. 1995; Hurt and Robertson 1998; Henning?eld et al. 2006; Henning?eld and Hartel 1999; Larson et al. 1961).

The past decade has witnessed a revolution in the attempts of scientists to under stand the molecular basis of dementia. Although dementia, as defined by global cogni tive decline involving gradual loss of memory, reasoning, judgment, and orientation, presents most commonly in the form of Alzheimer's disease (AD), an assortment of other less common disorders, such as prion and Pick's disease, can also lead to symp toms that are similar to those observed in patients with AD. The primary goal of Molecular Mechanisms of Dementia is to address the various mechanisms and multi faceted approaches currently being employed to more clearly delineate the etiological and pathogenic events responsible for the onset of dementia. Perhaps the greatest boon to obtaining a clearer understanding of the causes of AD has come from genetic and molecular biological studies carried out over the past decade. At the genetic level, it has become increasingly clear that AD is a heteroge neous disorder that can be broadly classified into two categories. "Late onset" (>60 yr) cases, which account for the vast majority of AD, genetically involve "susceptibility" genes representing risk factors for the disease (e. g. , inheritance of the 84 allele of the Apolipoprotein E gene). In many cases, the susceptibility gene can act as a "modifier" that modulates the pathogenic cascade occurring subsequent to a separate etiological event "initiating" or "causing" the disorder.